Streptococcus thermophilus and application thereof in fermentation of periplaneta americana

Through the fermentation of Streptococcus thermophilus thermophilus SN05, the content of bioactive substances was improved, the bottleneck of the development and application of traditional Chinese medicinal materials, the treatment and prevention effects of colon cancer and colitis were achieved, and the function was achieved. Sexual foods and biologics offer new applications.

CN119040209APending Publication Date: 2024-11-29SICHUAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411445677.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-16
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The prior art has failed to effectively utilize Streptococcus thermophilus to increase the content of active substances or produce new compounds in the fermentation of cockroaches of America, which limits the further development and application of the traditional Chinese medicinal cockroaches of America.

Method used

Streptococcus thermophilus strain SN05 fermented American cockroach powder, and the content of biologically active substances such as amino acids, organic oxygen compounds and benzene derivatives is improved through specific fermentation methods, and the effect of anti-colon cancer and preventing colitis is prepared. Biologics.

Benefits of technology

The content of bioactive substances in the American cockroach powder was significantly improved, showing the relief effect on the DSS-induced mouse colitis model and the inhibition and pro-apoptotic effects of human colon cancer cells, opening up functional foods and biological agents and provides new ideas for the development of traditional Chinese medicinal materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040209A_ABST
    Figure CN119040209A_ABST
Patent Text Reader

Abstract

The invention discloses streptococcus thermophilus and application of the streptococcus thermophilus in fermentation of periplaneta americana. The preservation number of the strain is CGMCC (China General Microbiological Culture Collection Center) The strain is separated and screened from traditional natural fermented yoghurt of Tibetan yak milk, grows well on an MRS agar culture medium, is not hemolyzed, is sensitive to various antibiotics, has better tolerance to acid, cholate, artificial gastric juice and artificial intestinal juice, and has a better inhibition effect on various common enteropathogenic bacteria. When the strain is used for fermenting American cockroach powder, the content of bioactive substances such as amino acids, organic oxygen compounds and benzene derivatives can be greatly increased, fermentation supernate of the strain has an obvious relieving effect on a DSS-induced mouse colitis model, symptoms are relieved, multiple inflammatory factor indexes are remarkably reduced, and the application prospect is broad. The fermentation supernate has the effects of inhibiting growth and promoting apoptosis on human colon cancer cells, so that the strain not only has remarkable application value in the fields of functional foods and biological agents, but also opens up a new way for further development and utilization of the traditional Chinese medicinal material periplaneta americana.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of microorganisms, and in particular relates to a strain of Streptococcus thermophilus and application thereof. Background Art

[0002] Streptococcus thermophilus is a Gram-positive bacterium belonging to the genus Streptococcus. It can grow and reproduce in high temperature environments, hence its name. This bacterium is widely found in nature, such as soil, animal feces and dairy products, and is widely used in the production of fermented dairy products, such as yogurt and cheese. It can decompose lactose to produce lactic acid, which helps the coagulation and flavor formation of dairy products. At the same time, it can also shorten the coagulation time of yogurt, increase the viscosity of yogurt, and improve the quality of yogurt. Streptococcus thermophilus is considered to be one of the important probiotics and has many health benefits. American cockroach is a traditional Chinese medicine. Kangfuxin liquid made from the ethanol extract of its dried insect body has the effects of promoting blood circulation, nourishing yin and promoting muscle growth, promoting granulation tissue growth, and promoting angiogenesis. It is widely used in clinical practice. If thermophilic streptococci can be used to ferment American cockroaches to increase the content of active substances or produce new compounds, it will provide new ideas for the further utilization of traditional Chinese medicine American cockroaches. Summary of the invention

[0003] The technical problem to be solved by the present invention is to provide a thermophilic streptococcus and the application thereof in the fermentation of American cockroaches.

[0004] The technical solution of the present invention is: a strain of Streptococcus thermophilus SN05, which was deposited in the General Microbiology Center of China Microbiological Culture Collection Administration on July 2, 2024, with the deposit address at No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, and the deposit number is CGMCC No.31141.

[0005] A biological preparation containing the above-mentioned Streptococcus thermophilus SN05 or its fermentation liquid.

[0006] The use of the above-mentioned Streptococcus thermophilus SN05 in the fermentation of American cockroaches.

[0007] The invention discloses an American cockroach powder fermentation liquid, which is obtained by fermenting the American cockroach powder with the above-mentioned Streptococcus thermophilus SN05.

[0008] Furthermore, the fermentation method is: prepare American cockroach powder and oligofructose into a culture medium with water, sterilize and cool, inoculate Streptococcus thermophilus SN05, culture at 37°C for 96 hours, centrifuge the fermentation liquid at 4000rpm and 4°C for 10 minutes, and filter the supernatant through a bacterial filter membrane to obtain a sterile supernatant.

[0009] The application of the above-mentioned American cockroach powder fermentation liquid in the preparation of medicine for treating or assisting in treating colon cancer.

[0010] An anti-colon cancer drug or an anti-colon cancer auxiliary drug contains the American cockroach powder fermentation liquid mentioned above.

[0011] The application of the American cockroach powder fermentation liquid in the preparation of medicine for preventing or treating colitis.

[0012] A medicine for preventing or treating colitis contains the American cockroach powder fermentation liquid mentioned above.

[0013] The application of the above-mentioned American cockroach powder fermentation liquid in the preparation of functional food.

[0014] Compared with the prior art, the present invention has the following beneficial effects:

[0015] The invention discloses a thermophilic streptococcus and its application in the fermentation of American cockroaches. The deposit number of the strain is CGM CC No.31141. The strain is separated and screened from the traditional natural fermented yogurt of yak milk in the Tibetan area, grows well on MRS agar medium, is non-hemolytic, is sensitive to multiple antibiotics, has good tolerance to acid, bile salts, artificial gastric juice and artificial intestinal juice, and has a good inhibitory effect on multiple common intestinal pathogens. The American cockroach powder fermented with the strain can greatly increase the content of bioactive substances such as amino acids, organic oxygen compounds and benzene derivatives, and the fermentation supernatant has a significant alleviating effect on the DSS-induced mouse colitis model, alleviates symptoms, and significantly reduces multiple inflammatory factor indicators. The fermentation supernatant has an inhibitory effect on the growth and apoptosis-promoting effect on human colon cancer cells. Therefore, the strain not only has significant application value in the field of functional foods and biological preparations, but also opens up a new way for the further development and utilization of the traditional Chinese medicine American cockroach.

[0016] Collection information:

[0017] Streptococcus thermophilus SN05 was deposited on July 2, 2024 at the General Microbiology Center of China Culture Collection Administration, with the deposit address at No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, with the deposit number CGMCC No.31141. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 This is a phylogenetic relationship diagram of the thermophilic Streptococcus SN05 strain in the present invention and other strains in GenBank.

[0019] Figure 2 This is the metabolome analysis of the supernatant of the American cockroach powder fermented by the thermophilic Streptococcus SN05 strain in the present invention. The volcano plot of the differential metabolites (the left picture is the positive ion mode, and the right picture is the negative ion mode)

[0020] Figure 3 The number of clones formed by HT-29 cells after being treated with the fermentation supernatant of Streptococcus thermophilus SN05 in the present invention, wherein A is the control group and B is the SN05 treatment group.

[0021] Figure 4 The ROS expression level of colon cancer cells after being treated with the fermentation supernatant of Streptococcus thermophilus SN05 in the present invention, wherein A is the control group and B is the SN05 treatment group.

[0022] Figure 5 This is the pro-apoptotic effect of the fermentation supernatant of Streptococcus thermophilus SN05 on HT-29 cells after treatment (control group on the left, SN05 treatment group on the right). DETAILED DESCRIPTION

[0023] The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples are purchased from commercial channels unless otherwise specified.

[0024] The standard strain LGG used in the following examples is Lactobacillus rhamnosus ATCC53103.

[0025] Experimental Example 1 Isolation and Identification of Streptococcus thermophilus SN05

[0026] 1.1 Material preparation

[0027] Yak traditional natural fermented yogurt samples were obtained from Nagqu City, Tibet;

[0028] 16S rRNA universal sequencing primers 27F and 1492R were synthesized by Sangon Biotechnology (Shanghai) Co., Ltd., and the sequences are as follows (5'→3'):

[0029] 27F: AGAGTTTGATCMTGGCTCAG (SEQ ID No. 1)

[0030] 1492R:GGTTACCTTGTTACGACTT(SEQ ID No.2)

[0031] MRS broth medium formula (per liter): casein digest 10.0g, beef extract powder 10.0g, yeast extract powder 4.0g, triammonium citrate 2.0g, sodium acetate 5.0g, magnesium sulfate heptahydrate 0.2g, manganese sulfate tetrahydrate 0.05g, dipotassium hydrogen phosphate 2.0g, glucose 20.0g, Tween-80 1.08g, final pH is about 5.7. Weigh each component according to the above ratio, add distilled water or deionized water to make up to 1L, dispense into conical flasks, and sterilize under high pressure conditions at 121℃ for 20min.

[0032] MRS agar medium formula (per liter): peptone 10.0g, beef powder 5.0g, yeast powder 4.0g, glucose 20.0g, Tween 80 1.0mL, potassium dihydrogen phosphate heptahydrate 2.0g, sodium acetate trihydrate 5.0g, ammonium citrate trihydrate 2.0g, magnesium sulfate heptahydrate 0.2g, manganese sulfate tetrahydrate 0.05g, agar 15.0g, the final pH is about 6.2. Weigh each component according to the above ratio, add distilled water or deionized water to make up to 1L, dispense into conical flasks, and sterilize under high pressure conditions at 121℃ for 20min.

[0033] 1.2 Screening and isolation of strains

[0034] Take a small amount of yogurt sample, inoculate it in 50mL MRS broth, shake it thoroughly and mix it, and place it in a constant temperature shaker at 37℃ for 24h. Take 1mL of the culture solution, dilute it by 10 times, take 20μL respectively, and spread it on MRS agar medium containing calcium carbonate (calcium carbonate 1.5g / 100mL). After culturing at 37℃ for 24h, pick a single colony with a large calcium dissolution circle, and separate and purify it three times in a row using the same method. Inoculate the purified strain into 600μL MRS broth medium, culture it in a shaker at 37℃ for 18h, add 400μL of 50% (V / V) sterile glycerol, and freeze it in a -80℃ ultra-low temperature refrigerator for later use.

[0035] 20 μL of the frozen bacterial strain was inoculated into MRS liquid medium for proliferation culture, and the strain DNA was extracted using the Tiangen Bacterial Genomic DNA Extraction Kit. PCR amplification was performed using the bacterial 16S rRNA universal primer 27F / 1492R with its total genomic DNA as a template to obtain a target gene sequence consisting of 1162 base pairs (bp), and the sequence is shown in SEQ ID No.3.

[0036] The gene sequence obtained by sequencing was input into the NCBI database for comparison. The similarity between the strain and the strain Streptococcus thermophilus strain 3802 in GenBank: MT538653.1 was 98.93%, and the strain was preliminarily identified as Streptococcus thermophilus. The phylogenetic relationship between this strain and other strains is shown in Figure 1. Figure 1 The strain was inoculated on MRS agar medium and cultured at 37°C for 24 hours. The morphology of single colonies was observed and recorded. Thermophilic Streptococcus SN05 grew well on MRS agar medium. It was milky white and round with smooth and raised surfaces. It was Gram-positive and arranged in chains, which was consistent with the characteristics of thermophilic Streptococcus.

[0037] The strain was named Streptococcus thermophilus SN05 and was deposited in the General Microbiology Center of China Culture Collection Administration on July 2, 2024. The deposit address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, with the deposit number CGMCC No.31141.

[0038] Experimental Example 2 Hemolytic Activity and Antibiotic Sensitivity Determination of Thermophilic Streptococcus SN05

[0039] Hemolysis is one of the important indicators for evaluating the safety of probiotics. Only when the strain shows non-hemolytic properties can it be considered safe. After activating the SN05 strain isolated and identified in Experimental Example 1, use an inoculation loop to streak on the MRS agar plate and select a single colony, then streak on the Columbia blood plate medium. After culturing for 24 hours, observe the hemolysis. The experiment was repeated three times. No hemolysis occurred around the thermophilic Streptococcus SN05 colony.

[0040] As the problem of antibiotic resistance becomes increasingly serious, it is crucial to select probiotics that are sensitive to antibiotics in order to prevent the spread of resistance genes. The sensitivity of the strains to common antibiotics was tested using the paper agar diffusion method. The thermophilic Streptococcus SN05 strain isolated and identified in Experimental Example 1 was activated and cultured, and the bacterial solution concentration was adjusted to 1×10 8CFU / mL, use a sterile cotton swab to evenly apply the bacterial solution on the surface of the MRS culture medium plate, place it at room temperature for 10 minutes, then put in the drug-sensitive paper, and culture it at 37°C for 18 hours. Use a vernier caliper to measure the diameter of the inhibition zone around each drug-sensitive paper. Repeat each antibiotic 3 times. The test results refer to the standards of the National Committee for Clinical Laboratory Standards (NCCLS) to judge the drug sensitivity of the strain. The results are expressed as sensitive (S), intermediate (I) and resistant (R). As shown in Table 1, thermophilic Streptococcus SN05 is sensitive (S) to the six antibiotics tested, including tetracycline, ampicillin, ceftriaxone, clarithromycin, chloramphenicol, and gentamicin, indicating that thermophilic Streptococcus SN05 has good safety (Table 1).

[0041] Table 1 Sensitivity of Streptococcus thermophilus SN05 to 6 antibiotics

[0042]

[0043] Experimental Example 3 Evaluation of acid and salt resistance of Streptococcus thermophilus SN05

[0044] 3.1 Acid resistance and bile salt resistance evaluation:

[0045] The SN05 strain isolated and identified in Experimental Example 1 was revived and activated, and the initial concentration of the bacterial solution was adjusted to 1×10 8 CFU / mL. MRS broth medium with pH 3.0 and bile salt concentration of 0.3% was prepared with hydrochloric acid and porcine bile salt respectively. The strain thermophilic Streptococcus SN05 was inoculated into the broth medium with pH 3.0 and bile salt concentration of 0.3% and the initial concentration of the bacterial solution was adjusted to 1×10 8 CFU / mL, after culturing at 37°C for 18h, take 20μL of bacterial solution and spread it on MRS agar plate medium, and observe whether there is colony growth on the surface of MRS plate after culturing at 37°C for 18h. The experiment was repeated 3 times. According to the results of the acid resistance and bile salt resistance test, thermophilic Streptococcus SN05 can still grow normal colonies on MRS agar plate after being treated in MRS broth medium with pH 3.0 and bile salt concentration of 0.3% for 18h. This strain has strong acid resistance and bile salt resistance.

[0046] 3.2 Simulated gastric juice and intestinal juice tolerance test:

[0047] Simulated gastric juice and intestinal juice were purchased from Shanghai Yuanye Biotechnology Co., Ltd.; the main components of artificial gastric juice simulation fluid were sodium chloride, dilute acid and pepsin, with a final pH of 2.5; the main components of artificial intestinal juice simulation fluid were phosphate and trypsin, with a final pH of 6.8. The thermophilic Streptococcus SN05 strain isolated and identified in Experimental Example 1 was revived and activated, and the bacterial solution was centrifuged at 4°C and 3500r / min for 10min, then washed 2-3 times with artificial gastric juice and resuspended, and the bacterial concentration was adjusted to 1×10 8 CFU / mL, 300μL of bacterial suspension was added to 2.7mL artificial simulated gastric fluid, and 20μL of the mixture was diluted 10 times to count the live bacteria as the initial value of tolerance to artificial gastric fluid; the simulated gastric fluid with live bacteria was cultured at 37℃ for 3h and the live bacteria were counted by the same method as the final value of tolerance to artificial gastric fluid. At the same time, 300μL of the above mixture was added to 2.7mL simulated intestinal fluid, and the above method was used to count the initial live bacteria. After culturing at 37℃ for 3h, the live bacteria were counted again. The experiment was repeated 3 times, with LGG as the control.

[0048] As shown in Table 2, Streptococcus thermophilus SN05 has good tolerance to artificial simulated gastric and intestinal fluids, and its comprehensive tolerance is comparable to that of the LGG strain, which is conducive to the survival of the strain in the gastrointestinal environment of humans and animals (Table 2).

[0049] Table 2 Tolerance of Streptococcus thermophilus SN05 strain to artificial simulated gastric and intestinal fluids (%)

[0050]

[0051] Experimental Example 4 Inhibitory ability of Streptococcus thermophilus SN05 strain against common intestinal pathogens

[0052] The proliferation of pathogenic bacteria in the intestine will cause the disorder of the intestinal flora system, thus causing a variety of diseases. Escherichia coli (CMCB 44102), Salmonella entericaserovar Paratyphi B (CMCB 50094), Pseudomonas aeruginosa (CMCB10104), Staphylococcus aureus (CMCB 26003), Salmonella typhimurium ATCC14028), Shigella dysenteriae (CMCB51105), and Yersinia enterocolitica subsp enterocolitica (CMCB52204) were revived and purified three times, and the activated pathogenic bacteria were inoculated into the liquid culture medium, and the bacterial solution concentration was adjusted to 1×10 8 CFU / mL. Take 60 μL of the above pathogenic bacteria solution and add it to 600 mL of solid agar medium cooled to 40-45°C after sterilization. Mix thoroughly and dispense into culture dishes at a rate of about 20 mL per dish. After the culture medium cools and solidifies, use a 6 mm diameter hole puncher to punch three holes on the plate as three replicate experiments. After the SN05 strain isolated and identified in Experimental Example 1 was revived, the bacterial solution concentration was adjusted to 1×10 8 CFU / mL, draw 50 μL of the test bacterial solution and add it to the wells of the above-mentioned pathogenic bacteria agar plate. After culturing at 37°C for 18 hours, use a vernier caliper to measure the diameter of the inhibition zone around the punch point (mm) and record it. LGG was used as a control. The results of the antibacterial activity evaluation of thermophilic Streptococcus SN05 are shown in Table 3 below. The fermentation broth of thermophilic Streptococcus SN05 strain has a strong inhibitory activity on the growth of pathogenic bacteria such as Salmonella paratyphi B, Staphylococcus aureus, Salmonella typhimurium, Shigella dysenteriae and Yersinia enterocolitica. The overall antibacterial effect is better than that of the LGG standard strain, and the inhibitory effect on Escherichia coli and Pseudomonas aeruginosa is slightly worse, indicating that the biological antibacterial agent prepared by thermophilic Streptococcus SN05 can be used to inhibit the growth and reproduction of the above-mentioned pathogens (Table 3).

[0053] Table 3 Evaluation of antibacterial activity of Streptococcus thermophilus SN05 strain (diameter: mm)

[0054]

[0055] Experimental Example 5 Application of Thermophilic Streptococcus SN05 in Fermentation of American Cockroach Powder

[0056] 5.1 Metabolomic analysis of fermentation supernatant

[0057] 5.1.1 Preparation of fermentation supernatant: 10 grams of American cockroach powder, 2 grams of oligofructose, and 100 mL of water were prepared into a culture medium. After sterilization and cooling, thermophilic Streptococcus SN05 was inoculated and cultured at 37 degrees for 96 hours. The fermentation broth was centrifuged at 4000 rpm and 4°C for 10 minutes. The supernatant was filtered through a bacterial filter membrane and sent to the company for non-targeted metabolomics analysis by liquid chromatography-mass spectrometry (LC-MS). The experiment was set up with three replicates, and the control group was not inoculated with probiotics. The culture and analysis methods were the same as those of the treatment group.

[0058] 5.1.2 Analysis method: Based on high-resolution mass spectrometry (HRMS) detection technology, the high-quality mzCloud database constructed by standards is combined with the mzVault and MassList databases to match and identify molecular characteristic peaks. The raw data is preprocessed using CD3.3 data processing software. First, simple screening is performed by parameters such as retention time and mass-to-charge ratio, and the peak area is quantified at the same time. Then, the high-resolution secondary spectrum databases mzCloud and mzVault and the MassList primary database are compared (searched) to identify metabolites. Using CD3.3 data processing software, the chromatographic peaks detected in the sample are integrated, where the peak area of ​​each characteristic peak represents the relative quantitative value of a metabolite. The total peak area is used to standardize the quantitative results, and finally the quantitative results of the metabolites are obtained. The results are expressed as the multiple increase in the content of the corresponding component in the sample compared with the control.

[0059] 5.1.3 Analysis results:

[0060] Metabolomics analysis showed that after 96 hours of fermentation of American cockroach powder with thermophilic Streptococcus SN05, 59 compounds were detected to have significantly increased levels, 93 compounds to have significantly decreased levels, and 777 compounds to have no significant differences in levels in the positive ion mode. In the negative ion mode, 40 compounds were detected to have significantly increased levels, 100 compounds to have significantly decreased levels, and 541 compounds to have no significant differences in levels. The metabolite difference volcano plot is shown in the figure below. Figure 2 .

[0061] (1) Amino acids and peptide compounds: Amino acids are the basic units that make up human proteins and they play a vital role in maintaining life. Amino acids participate in cell repair and growth, support immune system function, promote the synthesis of hormones and enzymes, and are essential for maintaining nerve conduction and muscle movement. Therefore, ensuring adequate amino acid intake is essential for promoting overall health and preventing diseases. The analysis results showed that after 96 hours of fermentation of American cockroach powder with Streptococcus thermophilus SN05, the content of various amino acids and their derivatives in the supernatant increased significantly, especially Pantetheine and Glutamate, which were 7.48 times and 5.85 times that of the control, respectively. Pantethine, also known as pantethine, is a derivative of vitamin B5 that can effectively regulate blood lipids, reduce serum triglycerides, low-density lipoprotein cholesterol and total cholesterol, and increase high-density lipoprotein cholesterol, thereby improving blood lipid levels and preventing hyperlipidemia. Pantethine can also regulate the composition, distribution and abundance of intestinal flora, which have protective and anti-inflammatory effects in the gastrointestinal tract and help improve intestinal health. Glutamate, or glutamate, is the main excitatory neurotransmitter in the central nervous system. It participates in various physiological processes such as learning, memory, emotion regulation, and pain perception by activating specific membrane receptors. It also plays a key role in cell energy metabolism, antioxidant response, and neuroprotection, and is essential for maintaining the normal function of the nervous system. The contents of many other amino acids have increased significantly (Table 4).

[0062] Table 4 Increase in the content of amino acids and peptides after SN05 strain fermented American cockroach powder

[0063]

[0064] (2) Organic oxygen compounds: Organic oxygen compounds are a class of compounds containing carbon and oxygen elements, and carbon and oxygen are connected by covalent bonds. They play an important role in nature and industrial production. They can be used as solvents, raw materials or intermediates and are widely used in chemical, pharmaceutical, food processing and other fields. In organisms, organic oxygen compounds play an important role. For example, glucose undergoes oxidation reaction to produce carbon dioxide and water, releasing energy to supply metabolic activities of organisms. In addition, many biologically active substances also belong to organic oxygen compounds, such as enzymes, hormones, vitamins, etc., which have important regulatory effects on life activities. The analysis results show that after the American cockroach powder was fermented with thermophilic Streptococcus SN05 for 96 hours, the content of some organic oxygen compounds in the supernatant increased significantly (Table 5). For example: D-Glucarate (D-glucaric acid) is a glucose derivative that can regulate hormone levels in the body, improve the body's immune function, and reduce the risk of cancer. D-Glucosamine-6-phosphate is the phosphorylated form of glucosamine, an amino sugar that plays multiple biological roles in the body, including serving as a precursor for the synthesis of cartilage and joint lubricant, and may help improve joint health.

[0065] Table 5 Increase in the content of organic oxygen compounds after SN05 strain fermented American cockroach powder

[0066]

[0067] (3) Benzene compounds: Benzene compounds are a class of organic compounds containing a benzene ring structure. They have a variety of potential positive effects in the human body, including antioxidant, anti-inflammatory, anti-tumor, skin health promotion, antifungal and antibacterial effects. In addition, this type of compound may also play a role in delaying aging, cardiovascular health and neuroprotection by inducing cell autophagy. At the same time, it plays an important role in protecting the skin from environmental damage and reducing inflammatory responses. It is an important ingredient in the fields of medical care and beauty skin care. The analysis results showed that after the American cockroach powder was fermented with thermophilic Streptococcus SN05 for 96 hours, the content of various benzene compounds in the supernatant increased greatly (Table 6), such as anisic acid, phenylpyruvic acid and gallic acid, the contents of which were 1731.15 times, 4.97 times and 3.92 times that of the control, respectively. Anisic acid is an important organic synthesis intermediate and modifier, widely used in medical, food and daily chemical industries. For example, the synthesis of methyl anisate and ethyl anisate, both of which are important raw materials for preparing flavors, toothpastes and dentifrice. Phenylpyruvic acid is used as a raw material for synthesizing L-phenylalanine, and can also be used in the preparation of sweeteners (aspartate), food nutritional enhancers and various anti-cancer drugs. Gallic acid has strong anti-inflammatory properties and can reduce the release of inflammatory factors by inhibiting the MAPK and NF-κB signaling pathways, thereby alleviating inflammatory responses.

[0068] Table 6 Growth multiples of benzene compound content after SN05 strain fermented American cockroach powder

[0069]

[0070]

[0071] (4) Other differential metabolites: In addition to amino acid compounds, organic oxygen compounds and benzene substances, the analysis results showed that after 96 hours of fermentation of American cockroach powder by Streptococcus thermophilus SN05, the content of other differential metabolites in the supernatant also increased significantly, such as spermine, alpha-ketoglutaric acid, histamine and xanthosine, which increased by 16.36 times, 9.82 times, 8.55 times and 7.61 times respectively compared with the control group (Table 7). Spermidine is a polyamine compound that has many positive effects on the human body. It has potential benefits in anti-aging, neuroprotection, cardiovascular health maintenance, immune regulation and improvement of metabolic diseases through mechanisms such as promoting cell autophagy, enhancing antioxidant defense, regulating cell proliferation and differentiation, protecting nerve cells, improving cardiovascular health, regulating the immune system, delaying brain aging, and enhancing anti-tumor immune response in cancer treatment. α-ketoglutarate is a key metabolic intermediate in the tricarboxylic acid cycle. This naturally occurring compound in the human body is involved in a variety of metabolic and cellular pathways in cells. As a precursor of glutamate and glutamine, α-ketoglutarate connects carbohydrate and nitrogen metabolism in multiple tissues and is essential for the protection of amino acids and the detoxification of ammonia. Histamine, as a bioactive substance in the human body, participates in the regulation of key physiological processes such as sleep-wake cycles, emotions, learning, and memory by binding to different types of histamine receptors, and plays a positive role in neuroprotection, immunomodulation, inflammatory response control, and cardiovascular health. At the same time, it may contribute to tumor treatment and the improvement of microcirculation in some cases. It is an important molecule for maintaining normal body function and promoting health. Xanthine is a purine compound. The latest study found that Xanthosine can enhance glucose uptake and reduce glucose production by regulating the AMPK / FoxO1 / AKT / GSK3β signaling pathway, thereby helping to regulate glucose homeostasis in the liver.

[0072] Table 7 Increase multiples of other differential metabolites after SN05 strain fermented American cockroach powder

[0073]

[0074] 5.2 Growth inhibition and apoptosis-promoting effects of fermentation supernatant on human colon cancer cells

[0075] 5.2.1 Growth inhibition ability of fermentation supernatant on HT-29 cells:

[0076] (1) Cell culture: Take out the HT-29 culture dish of human colon cancer cells, remove the culture medium, add 1 mL of PBS for washing, add 1 mL of trypsin after removal, mix gently, digest for 2 min, until the cells are observed to be round under an optical microscope, then remove the trypsin, add 1 mL of culture medium, use a pipette to suspend the cells, and transfer them to a 1.5 mL EP tube. Centrifuge at 1200 rpm / min for 3 min, remove the supernatant, add 300 μL of culture medium and mix thoroughly, pipette 150 μL into the culture dish containing 4 mL of culture medium, mix gently, place in a CO2 incubator for continued culture, and operate according to the cell passaging method until centrifugation after 48 h. Discard the supernatant, mix the cells with 1 mL of culture medium, and then count them with a hemocytometer, and dilute the cell suspension to 3×10 4 CFU / mL. Add 100 μL of cell suspension to each well of the 96-well cell plate and place in a CO2 incubator for culture. After the cells adhere to the wall and grow well, remove the culture medium for later use.

[0077] (2) Cytotoxicity test: The preparation method of the supernatant of the fermentation of Streptococcus thermophilus SN05 strain in American cockroaches is as described in 5.1.1. It is added to the serum-free cell culture medium at 4% (v / v), and 100 μL is added to each cell culture well. The cells are cultured for 24 h, 48 h, and 72 h, respectively. The serum-free cell culture medium without fermentation supernatant is used as the control, and three replicates are set.

[0078] (3) CCK-8 detection of cell proliferation: aspirate the culture medium of the cytotoxicity experiment, add 100 μl of CCK-8 solution to each well, continue to culture in the incubator for 1.5 h, and measure the OD562 value with an enzyme marker to indicate cell growth activity.

[0079] (4) Results analysis

[0080] The test results are shown in Table 8. The fermentation supernatant of Streptococcus thermophilus SN05 has a growth inhibitory effect on human colon cancer HT-29 cells. After treatment for 24h, 48h or 72h, the growth inhibition rates were 35.01%, 7.57% and 12.61%, respectively.

[0081] Table 8 Inhibitory effect of the fermentation supernatant of Streptococcus thermophilus SN05 on the growth of HT-29 cells (%)

[0082]

[0083] 5.2.2 Effect of fermentation supernatant on HT-29 cell colony formation ability:

[0084] Resuscitate and subculture colon cancer cell HT-29 cells, plate at a density of 2000 cells per well in a 6-well plate, and culture for 3 weeks in a serum-free medium containing 1% fermentation supernatant (the preparation method of fermentation supernatant is described in 5.1.1), and replace fresh medium every two days to ensure good cell growth. After the formation of visible clones in the cell culture plate, discard the medium, wash with PBS, fix with methanol for 30min-2h, add 1% crystal violet staining for 30min, wash off the residual crystal violet staining solution, dry the culture plate, count under a microscope, and set up 3 replicates of the experiment.

[0085] The results showed that 1% of the fermentation supernatant of Streptococcus thermophilus SN05 strain had a significant effect on the colony formation ability of HT-29 cells. The number of cell colonies in the treatment group was only 56.85% of that in the control group, further indicating that its fermentation broth had a significant inhibitory effect on the growth of human colon cancer cells (Table 9, Figure 3 ).

[0086] Table 9 Number of clone-forming cells after treatment with the fermentation supernatant of Streptococcus thermophilus SN05

[0087]

[0088]

[0089] Note: Compared with the control group, **p<0.01

[0090] 5.2.3 Effect of fermentation supernatant on reactive oxygen species (ROS) levels in HT-29 cells:

[0091] Cell collection: After incubating the SN05 fermentation supernatant (the preparation method of the fermentation supernatant is described in 5.1.1) with the adherent cultured HT-29 cells for 48 hours, the fermentation supernatant was aspirated and repeatedly blown with serum-free culture medium. The bottom of the well plate (bottom of the bottle) was observed by naked eyes to change from translucent (cell monolayer connected into a sheet) to transparent, and almost all the cell layers were blown into the culture medium. Collect all the cell suspensions in a 1.5mL centrifuge tube. Wash twice with serum-free culture medium, 1000r / min, centrifuge for 5min, aspirate the supernatant, and keep the cell pellet for determination.

[0092] Loading probe: Dilute DCFH-DA with serum-free culture medium at 1:1000 to a final concentration of 10μmol / L. After collecting cells, suspend them in the diluted DCFH-DA at a cell concentration of 1 million to 20 million / mL and incubate in a 37°C cell culture incubator for 20 minutes. Invert and mix every 3-5 minutes to allow the probe and cells to fully contact. Wash the cells 3 times with serum-free cell culture medium to fully remove the DCFH-DA that has not entered the cells.

[0093] Detection: Use an inverted fluorescence microscope to detect the intensity of fluorescence at an excitation wavelength of 488 nm and an emission wavelength of 525 nm. Use the supernatant of MRS liquid culture medium as the negative control group, and the experiment is repeated 3 times.

[0094] The level of reactive oxygen species (ROS) reflects the state of cellular metabolites. Under normal circumstances, the generation and removal of ROS are in a dynamic balance. If the ROS level exceeds the normal range, it may cause oxidative damage or cell death. The number of cells expressing reactive oxygen species and the fluorescence intensity of HT-29 cells treated with SN05 fermentation supernatant were significantly higher than those in the control group, indicating that SN05 fermentation supernatant may have a pro-apoptotic effect on colon cancer cells (Table 10, Figure 4 ).

[0095] Table 10 Average number of cells expressing ROS

[0096]

[0097] Note: Compared with the Control group, **p<0.01

[0098] 5.2.4 Pro-apoptotic ability of fermentation supernatant on human colon cancer HT-29 cells:

[0099] One-step TUNEL cell apoptosis detection was used. After incubating the SN05 fermentation supernatant (the preparation method of the fermentation supernatant is as described in 5.1.1) with the adherent cultured HT-29 cells for 48 hours, the fermentation supernatant was aspirated and washed once with PBS. Fix the cells with 4% paraformaldehyde for 30 minutes and wash again with PBS. Add PBS containing 0.3% Triton X-100 and incubate at room temperature for 5 minutes. Prepare the TUNEL detection solution and mix it thoroughly. Add 50μL TUNEL detection solution to the HT-29 cells and incubate at 37°C in the dark for 60 minutes. Wash 3 times with PBS, then seal the slide with anti-fluorescence quenching sealing solution and observe under an inverted fluorescence microscope. The excitation wavelength is 550nm and the emission wavelength is 570nm. The supernatant of MRS liquid culture medium was used as the negative control group, and the experiment was repeated 3 times.

[0100] The results showed that after treatment with SN05 fermentation supernatant, the number of apoptotic HT-29 cells increased significantly and the fluorescence intensity of the marker increased, further proving that SN05 fermentation supernatant has a significant effect in promoting HT-29 cell apoptosis (Table 11, Figure 5 ).

[0101] Table 11 Pro-apoptosis ability of SN05 fermentation supernatant on human colon cancer cells

[0102]

[0103] Note: Compared with the Control group, **p<0.01

[0104] 5.2.5 Preventive effect of fermentation supernatant on colitis model in mice

[0105] (1) DSS aqueous solution: Dextran sulfate sodium salt (DSS) was used to prepare an aqueous solution with a concentration of 4% (w / v).

[0106] (2) Fermentation supernatant: The preparation method of the fermentation supernatant of Streptococcus thermophilus SN05 strain of American cockroaches is as described in 5.1.1. Experimental animals: 27 4-week-old SPF male Kunming mice were provided by Chengdu Dashuo Experimental Animal Co., Ltd. and randomly divided into 9 cages, 3 mice in each cage. After adaptive feeding, they were randomly divided into 3 groups, 3 cages in each group, including a blank control group (CK), a DSS model group (DSS), and a Streptococcus thermophilus SN05 treatment group (SN05 treatment group). The experimental treatments are shown in Table 12.

[0107] Table 12DSS-induced colitis experiment in mice

[0108]

[0109] (3) Detection of serum inflammatory factors: At the end of the experiment, three mice were randomly killed in each group, and blood was collected from the eye sockets. The blood was centrifuged at 3000 r / min for 15 min to obtain serum. The inflammatory factors (IL-1β, IL-6, IL-8 and TNF-α) in the serum were determined using ELISA kits according to the instructions of the kit.

[0110] (4) Organ index and colorectal length: After the modeling period, three mice in each group were killed and dissected. The spleen and liver were quickly removed, rinsed with saline, dried with filter paper, and weighed. The colorectal length was measured with a ruler.

[0111] Organ index = spleen or liver mass (g) / mouse body weight (g) × 100%

[0112] (5) Results analysis

[0113] The results of blood inflammatory factor detection showed that the four inflammatory factor indicators of IL-1β, IL-6, IL-8 and TNF-α in the DSS model group increased rapidly and were significantly higher than those in the control group. Although the levels of the four inflammatory factors in the serum of mice in the SN05 treatment group were higher than those in the control group, they were significantly lower than those in the DSS model group, indicating that the fermentation supernatant of Streptococcus thermophilus SN05 strain had a significant alleviating effect on DSS-induced colon inflammation in mice (Table 13).

[0114] Table 13 Changes in the concentration of each inflammatory factor in the serum of each group of mice (x±SD) (unit: pg / mL)

[0115]

[0116] Note: Compared with the blank control group, *p<0.05, **p<0.01; compared with the DSS model group, #p<0.05, ##p<0.01

[0117] The autopsy revealed that the spleen index of the DSS model group increased, the liver index decreased, and the colorectal length was significantly shortened. After intervention with thermophilic Streptococcus SN05 fermentation liquid, the organ index and colorectal length of the mice were close to those of normal mice (Table 14).

[0118] Table 14 Changes in organ index and colorectal length in mice

[0119]

[0120] Note: Compared with the blank control group, *p<0.05, **p<0.01; compared with the DSS model group, #p<0.05, ##p<0.01.

Claims

1. A strain of Streptococcus thermophilus SN05 was deposited in the General Microbiological Center of China Microbiological Culture Collection Administration with the deposit number of CGMCC No.31141.

2. A biological preparation containing the Streptococcus thermophilus SN05 or its fermentation liquid according to claim 1.

3. Use of the Streptococcus thermophilus SN05 according to claim 1 in fermenting American cockroaches.

4. An American cockroach powder fermentation liquid, characterized in that: Obtained by fermenting American cockroach powder by Streptococcus thermophilus SN05 as described in claim 1.

5. The American cockroach powder fermentation liquid according to claim 4, characterized in that: The fermentation method comprises the following steps: preparing a culture medium with American cockroach powder and oligofructose with water, sterilizing and cooling the culture medium, inoculating thermophilic streptococcus (Streptococcusthermophilus) SN05, culturing the culture medium at 37°C for 96 hours, centrifuging the fermentation liquid at 4000 rpm and 4°C for 10 minutes, and filtering the supernatant with a bacterial filter membrane to obtain a sterile supernatant.

6. Use of the American cockroach powder fermentation liquid according to claim 4 or 5 in preparing a medicine for treating or assisting in treating colon cancer.

7. An anti-colon cancer drug or an anti-colon cancer auxiliary drug, characterized in that: Contains the American cockroach powder fermentation liquid according to claim 4 or 5.

8. Use of the American cockroach powder fermentation liquid according to claim 4 or 5 in the preparation of a medicament for preventing or treating colitis.

9. A drug for preventing or treating colitis, characterized in that: Contains the American cockroach powder fermentation liquid according to claim 4 or 5.

10. Use of the American cockroach powder fermentation liquid according to claim 4 or 5 in preparing functional foods.